Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Brentuximab + Lenalidomide for T-Cell Lymphoma
Recruiting3 awardsPhase 2
Columbus, Ohio
This trial is studying brentuximab vedotin and lenalidomide to see how well they work in treating patients with stage IB-IVB T-cell lymphoma that have come back or do not respond to treatment.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.